| MolName | (4S,6S)-4-[[(2R)-4-carboxy-2-[[(2S)-2-[[(2S)-4-carboxy-2-[[(2S)-3-carboxy-2-(3-carboxypropanoylamino)propanoyl]amino]butanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]butanoyl]amino]-6-formyl-5-oxonon-8-ynoic acid |
| MolecularFormula | C37H44N5O17Cl |
| Smiles | C#CC[C@@H](C=O)C([C@H](CCC(O)=O)NC([C@@H](CCC(O)=O)NC([C@H](Cc(cc1)ccc1Cl)NC([C@H](CCC(O)=O)NC([C@H](CC(O)=O)NC(CCC(O)=O)=O)=O)=O)=O)=O)=O |
| InChI | InChI=1S/C37H44ClN5O17/c1-2-3-20(18-44)33(56)22(8-12-28(46)47)40-34(57)23(9-13-29(48)49)41-36(59)25(16-19-4-6-21(38)7-5-19)43-35(58)24(10-14-30(50)51)42-37(60)26(17-32(54)55)39-27(45)11-15-31(52)53/h1,4-7,18,20,22-26H,3,8-17H2,(H,39,45)(H,40,57)(H,41,59)( |
| InChIK | QXOREIQIFYBYQL-QCMPWGGGSA-N |
| TotalMolweight | 866.227 |
| Molweight | 866.227 |
| MonoisotopicMass | 865.242077 |
| CLogP | -3.0414 |
| CLogS | -4.039 |
| H Acceptors | 22 |
| H Donors | 10 |
| TotalSurfaceArea | 642.69 |
| Relative PSA | 0.43455 |
| PolarSurfaceArea | 366.14 |
| Druglikeness | -1.0147 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | |
| Shape Index | 0.4 |
| Fragments | 1 |
| Non HAtoms | 60 |
| NonCHAtoms | 23 |
| Electronegative Atoms | 23 |
| StereoCenters | 6 |
| Rotatable Bond | 29 |
| Rings Closures | 1 |
| Small Rings | 1 |
| Aromatic Rings | 1 |
| Aromatic Atoms | 6 |
| Sp3Atoms | 22 |
| Symmetricatoms | 2 |
| Amides | 5 |
| AcidicOxygens | 5 |
| StereoCon | this enantiomer |
Click to Load Molecule:
1 - (4S,6S)-4-[[(2R)-4-carboxy-2-[[(2S)-2-[[(2S)-4-carboxy-2-[[(2S)-3-carboxy-2-(3-carboxypropanoylamino)propanoyl]amino]butanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]butanoyl]amino]-6-formyl-5-oxonon-8-ynoic acid | 2 - (4S,6S)-4-[[(2R)-4-carboxy-2-[[(2S)-2-[[(2S)-4-carboxy-2-[[(2S)-3-carboxy-2-(3-carboxypropanoylamino)propanoyl]amino]butanoyl]amino]-3-(4-chlorophenyl)propanoyl]amino]butanoyl]amino]-6-formyl-5-oxonon-8-ynoic acid